GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...
(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.
The posterior end of IT had the highest normal epithelium percentage. Chronic nasal obstruction caused by inferior turbinate (IT) hypertrophy is one of the most common problems encountered in ...
After examining Contos' bill, Littenberg said it's standard for providers to bill for two colonoscopies if they remove two or more polyps in different ways, because of the extra work. As in this ...